Book excerpt from CRISPR People

In Chapter 6, author Henry T. Greely describes how news of the birth of gene-edited babies rocked a 2018 summit on human genome editing.

Written byHenry T. Greely
| 9 min read
Hong Kong skyline with a pink sky in the background

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

ABOVE: © ISTOCK.COM, AMNAD

The Summit was to begin on Tuesday morning, November 27; He was to talk on Wednesday, November 28. [Robin] Lovell-Badge gives some background on the timing of and reason for He’s speaking role:

A month or so before the Second International Summit on Human Genome Editing took place, several of us on the organizing committee heard rumors that He Jiankui . . . was using genome-editing techniques on human embryos for the purposes of trying to make children who would be resistant to infection by HIV. We knew that JK had presented relevant work, involving genome editing in mouse and monkey embryos, at meetings over the last couple of years, and that he had also started using the methods on human embryonic stem cells and human embryos in culture. However, there was concern that he felt he was in a position to try things for real: ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies